Nuclear Medicine/ Radiopharmaceuticals Market is Set to Boom by 2022
Nuclear Medicine/ Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine.
Nuclear Medicine/ Radiopharmaceuticals Market is expected to garner $8,207.5 million by 2022. The market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Company Profiles<br />
<strong>Nuclear</strong> <strong>Medicine</strong>/<strong>Radiopharmaceuticals</strong> <strong>Market</strong><br />
1. Mallinckrodt plc.<br />
2. General Electric Co.<br />
3. Medtronic, plc. (Covidien, acquired <strong>by</strong> Medtronic)<br />
4. Bayer AG<br />
5. Cardinal Health, Inc.<br />
6. Lantheus Medical Imaging, Inc.
Change language